Light Mode
$17.29 ↑ +0.00 (+0.00%) Trading Up from the previous close of $17.29, $0.96 below the day’s high of $18.25
+6.94 (+67.05%) / 6M
Momentum, market sentiment, and recent alerts
CYRX reads neutral: price sits above one of the two key moving averages, the 12-month move is +91.3%.
No alerts for CYRX in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Cryoport, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.